AU2002235764A1 - Transdermal system containing a novel high potency progestagen - Google Patents
Transdermal system containing a novel high potency progestagenInfo
- Publication number
- AU2002235764A1 AU2002235764A1 AU2002235764A AU3576402A AU2002235764A1 AU 2002235764 A1 AU2002235764 A1 AU 2002235764A1 AU 2002235764 A AU2002235764 A AU 2002235764A AU 3576402 A AU3576402 A AU 3576402A AU 2002235764 A1 AU2002235764 A1 AU 2002235764A1
- Authority
- AU
- Australia
- Prior art keywords
- system containing
- progestagen
- transdermal system
- novel high
- high potency
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
Abstract
The invention relates to a matrix transdermal system containing (21S)-21-hydroxy-21-methyl-14,17-ethano-19-norpregna-4,9,15-triene-3,2 0-dione comprising a polyacrylate adhesive.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00250449.6 | 2000-12-21 | ||
EP00250449A EP1216699A1 (en) | 2000-12-21 | 2000-12-21 | Transdermal system comprising a highly potent progestin |
PCT/EP2001/014538 WO2002049622A2 (en) | 2000-12-21 | 2001-12-11 | Transdermal system containing a novel high potency progestagen |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002235764A1 true AU2002235764A1 (en) | 2002-07-01 |
Family
ID=8172629
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002235764A Abandoned AU2002235764A1 (en) | 2000-12-21 | 2001-12-11 | Transdermal system containing a novel high potency progestagen |
Country Status (7)
Country | Link |
---|---|
US (1) | US20030003139A1 (en) |
EP (2) | EP1216699A1 (en) |
JP (1) | JP2004525872A (en) |
AT (1) | ATE396713T1 (en) |
AU (1) | AU2002235764A1 (en) |
DE (1) | DE50114006D1 (en) |
WO (1) | WO2002049622A2 (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10234525A1 (en) * | 2002-07-25 | 2004-02-05 | Schering Ag | New compositions, useful as male contraceptives, comprise synergistic active agent combination of androgenic 11beta-halo-steroid and gestagenic 14 alpha, 17alpha-ethylene-estratrienone derivative |
ES2299735T3 (en) * | 2002-07-25 | 2008-06-01 | Bayer Schering Pharma Aktiengesellschaft | COMPOSITION, CONTAINING AN ANDROGEN 11-BETA-HALOGEN-STEROID AND A GESTAGEN, AS WELL AS A MALE ANTI-CONCEPT ON THE BASIS OF THIS COMPOSITION. |
DE102010040299A1 (en) | 2010-09-06 | 2012-03-08 | Bayer Schering Pharma Aktiengesellschaft | Transdermal therapeutic systems with crystallization-inhibiting protective film (release liner) |
PL2782584T3 (en) | 2011-11-23 | 2021-12-13 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10206932B2 (en) | 2014-05-22 | 2019-02-19 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
WO2017173044A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd Inc. | Steroid hormone compositions in medium chain oils |
AU2017239645A1 (en) | 2016-04-01 | 2018-10-18 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
CN110139641B (en) * | 2016-12-28 | 2022-09-09 | 富士胶片富山化学株式会社 | External composition |
EP3395336A1 (en) * | 2017-04-28 | 2018-10-31 | Nitto Denko Corporation | Transdermal absorption preparation |
US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5474783A (en) * | 1988-03-04 | 1995-12-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
US5656286A (en) * | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
JP2552716B2 (en) * | 1988-10-11 | 1996-11-13 | 積水化学工業株式会社 | Transdermal patch |
DE4405898A1 (en) * | 1994-02-18 | 1995-08-24 | Schering Ag | Transdermal therapeutic systems containing sex steroids |
DE4447401A1 (en) * | 1994-12-23 | 1996-07-04 | Schering Ag | 14.17-C¶2¶-bridged steroids |
DE19526864A1 (en) * | 1995-07-22 | 1997-01-23 | Labtec Gmbh | Hormone patches |
DE19848303A1 (en) * | 1998-10-14 | 2000-04-20 | Schering Ag | Stable combination of 14,17-over-bridged steroid gestagen and cyclodextrin compound, useful for treating climacteric disorders or for contraception |
-
2000
- 2000-12-21 EP EP00250449A patent/EP1216699A1/en not_active Withdrawn
-
2001
- 2001-12-11 JP JP2002550964A patent/JP2004525872A/en active Pending
- 2001-12-11 DE DE50114006T patent/DE50114006D1/en not_active Expired - Fee Related
- 2001-12-11 WO PCT/EP2001/014538 patent/WO2002049622A2/en active IP Right Grant
- 2001-12-11 EP EP01985863A patent/EP1343483B1/en not_active Expired - Lifetime
- 2001-12-11 AT AT01985863T patent/ATE396713T1/en not_active IP Right Cessation
- 2001-12-11 AU AU2002235764A patent/AU2002235764A1/en not_active Abandoned
- 2001-12-20 US US10/022,834 patent/US20030003139A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2004525872A (en) | 2004-08-26 |
EP1216699A1 (en) | 2002-06-26 |
ATE396713T1 (en) | 2008-06-15 |
US20030003139A1 (en) | 2003-01-02 |
DE50114006D1 (en) | 2008-07-10 |
WO2002049622A2 (en) | 2002-06-27 |
EP1343483A2 (en) | 2003-09-17 |
WO2002049622A3 (en) | 2003-01-09 |
EP1343483B1 (en) | 2008-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002235764A1 (en) | Transdermal system containing a novel high potency progestagen | |
AU2001274078A1 (en) | Prepolymeric (meth)acrylates with polycyclic or aromatic segments | |
MY107158A (en) | 3-arylcarbonyl; -1h-indoles useful as therapeutic agents. | |
HK1112007A1 (en) | Peptide acceptor ligation methods | |
WO1999064047A8 (en) | Novel antiviral compounds | |
AU4305801A (en) | Water vapor-permeable, pressure-sensitive adhesives | |
EP1337336B8 (en) | Reaction plate | |
TW200716550A (en) | Pharmaceutical composition comprising ritonavir | |
AU3721500A (en) | High pressure syringe | |
AP2001002220A0 (en) | Calcilytic compounds. | |
AU2001274894A1 (en) | Novel matrix metalloproteinases | |
AU7210298A (en) | Use of an extract of alchemilli vulgaris | |
AU1071901A (en) | 23431, a novel human ubiquitin protease | |
AU3440001A (en) | Stamp adhesive | |
EP1469000A4 (en) | Novel crystalline tricyclic triazolobenzazepine derivative | |
AU1932997A (en) | Dosage forms and uses | |
AU2002222695A1 (en) | Novel 4'-demethyl-4'-o-substituted-1-deoxypodophyllotoxin derivative and geometric isomer thereof, process for the preparation thereof and anti-cancer composition comprising the same | |
AU1038501A (en) | Novel processes | |
AUPP979099A0 (en) | Ioniser for effluent gas | |
AU2001245463A1 (en) | 26583, a novel serine/threonine phosphatase and uses therefor | |
EP0948961A3 (en) | Effervescent tablet comprising Calcium with an antihistaminic as active agent | |
AU5681000A (en) | Dust-free calcium formate | |
AU5274099A (en) | Hiv vaccine | |
AU2290401A (en) | Novel processes | |
WO2001032201A3 (en) | A pharmaceutical composition having high cell membrane permeability |